Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
07/2012
07/18/2012CN102584833A Separation method for mixture of triethylene-diamine and ethanolamine
07/18/2012CN102584832A Method for extracting and purifying Nazlinin
07/18/2012CN102584831A Preparation method for zaleplon
07/18/2012CN102584830A Dihydroindene amide compounds, and medicinal composition and application thereof
07/18/2012CN102584829A Pyrazole and pyrazine diketone derivative and application thereof
07/18/2012CN102584828A Pyrrolidine[3,4-d]pyrimidine derivative and preparation method and application thereof
07/18/2012CN102584816A Method for preparing polycycle tertiary amine
07/18/2012CN102584800A Compound containing framework of chiral indolone and angelica lactone and asymmetric synthesis method
07/18/2012CN102584799A Aromatic nitrogenous six-membered ring compounds
07/18/2012CN101880283B Azaindole kinase inhibitors
07/18/2012CN101812064B Method for preparing acetamido metal naphthalene phthalocyanine
07/18/2012CN101735223B Piperazine ketone-nitrogen heterocyclic compound and synthesis method
07/18/2012CN101631790B Compounds for the treatment of hepatitis c
07/18/2012CN101501038B Fused [d]pyridazin-7-ones
07/18/2012CN101374845B Novel compounds and use thereof
07/17/2012US8222405 Phenylalanine derivatives
07/17/2012US8222289 Salinosporamides and methods for use thereof
07/17/2012US8222288 Small molecule inhibitors of MDM2 and the uses thereof
07/17/2012US8222265 Six-membered N-heterocyclic carbene-based catalysts for asymmetric reactions
07/17/2012US8222259 1,2,4-triazolo[4,3-c]pyrimidin-3-one and pyrazolo[4,3-e]-1,2,4-triazolo[4,3-c]pyrimidin-3-one compounds for use as adenosine A2a receptor antagonists
07/17/2012US8222257 Phosphono-pent-2-en-1-yl nucleosides and analogs
07/17/2012US8222251 Pyridopyridazine compounds, compositions and methods of use
07/17/2012US8222244 Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity
07/17/2012US8222242 Nitric oxide releasing compounds
07/17/2012CA2637658C Aurora kinase modulators and method of use
07/17/2012CA2522561C Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
07/12/2012WO2012093809A2 New bicyclic compound for modulating g protein-coupled receptors
07/12/2012WO2012093169A1 Novel sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
07/12/2012WO2012092880A1 2,4-DIAMINO-6,7-DIHYDRO-5H-PYRROLO[2,3]PYRIMIDINE DERIVATIVES AS FAK/Pyk2 INHIBITORS
07/12/2012US20120178927 Cycloalkylphenyl substituted cyclic ketoenols
07/12/2012US20120178926 Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
07/12/2012US20120178915 Pyrimidine derivatives and analogs, preparation method and use thereof
07/12/2012US20120178770 Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors
07/12/2012US20120178769 Novel compounds for inhibiting eef-2 kinase activity
07/12/2012US20120178751 2-arylimidazo[1,2-b]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives
07/12/2012US20120178748 Heteroaryl compounds and methods of use thereof
07/12/2012US20120178744 FUSED TRICYCLIC COMPOUNDS AS NOVEL mTOR INHIBITORS
07/12/2012US20120178740 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors
07/12/2012US20120178736 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
07/12/2012US20120178734 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
07/12/2012US20120178730 Sod-imitating metal complexes
07/12/2012US20120178715 SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS
07/12/2012US20120175598 Carbazole derivative and organic electroluminescent devices utilizing the same and fabrication method thereof
07/12/2012CA2823969A1 2,4-diamino-6,7-dihydro-5h-pyrrolo[2,3]pyrimidine derivatives as fak/pyk2 inhibitors
07/12/2012CA2823935A1 Novel sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
07/11/2012EP2474549A1 Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type I inhibitors
07/11/2012EP2474546A1 Thiophene-carboxamides useful as inhibitors of protein kinases
07/11/2012EP2474545A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
07/11/2012EP2473564A1 Naphthalocyanine dye and ink containing the same
07/11/2012EP2473511A1 Pteridines and their use as agrochemicals
07/11/2012EP2473500A2 Benzimidazole derivatives
07/11/2012EP2473498A1 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
07/11/2012EP2473490A1 (thio)morpholine derivatives as s1p modulators
07/11/2012EP2473055A1 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
07/11/2012EP2473047A1 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
07/11/2012EP2473041A1 Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
07/11/2012EP2094081B1 Tricyclic heteroaromatic compounds as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
07/11/2012EP1891074B1 Azabicyclic heterocycles as cannabinoid receptor modulators
07/11/2012EP1471056B1 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
07/11/2012CN1805937B N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine D3 receptor.
07/11/2012CN102574863A Heterocyclic compounds as JANUS kinase inhibitors
07/11/2012CN102574862A Method of preparing sitagliptin and intermediates used therein
07/11/2012CN102574861A Methylpyrrolopyrimidinecarboxamides
07/11/2012CN102574860A Pyrrolo[2,3-d]pyrimidine compounds
07/11/2012CN102574859A [18 F] - labelled analogues of flumazenil as in vivo imaging agents
07/11/2012CN102574858A Bicyclic heterocycles and their use as CCR2 receptor antagonists
07/11/2012CN102574857A Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors
07/11/2012CN102574856A Sitagliptin synthesis
07/11/2012CN102574855A Pteridines and Their use as agrochemicals
07/11/2012CN102574852A AKT inhibitors
07/11/2012CN102574848A Materials for organic electroluminescent devices
07/11/2012CN102574840A R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same
07/11/2012CN102574815A Mesoionic pesticides
07/11/2012CN102558199A Tetradentate schiff base metal complexes, metal porphyrin complexes and preparing method of polycarbonate
07/11/2012CN102558187A Tetrahydroporphin compound and preparation method and application thereof
07/11/2012CN102558186A Preparation of chloroaluminum phthalocyanine nanometer particles by using wet method and application of chloroaluminum phthalocyanine nanometer particles in visible light responsive photodegradation
07/11/2012CN102558185A Pyrido-pyrrole triazine compound, and preparation method and application thereof
07/11/2012CN102558184A Synthesis method of phthalazine derivative
07/11/2012CN102558183A Pyrrolidine pyrazolyl oxo-quinoline carboxylic acid compound
07/11/2012CN102558140A Derivatives of 4-piperazin-1-1-yl-4-benzo [b] thiophene suitable for the treatment of cns disorders
07/11/2012CN102557982A Certain chemical entities, compositions, and methods
07/11/2012CN101641360B Piperazine derivatives, preparation process and pharmaceutical use thereof
07/11/2012CN101384600B Crystalline forms of (3r,4r)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methol]piperidin-3-ol
07/11/2012CN101282978B Macrocylic inhibitors of hepatitis c virus
07/10/2012US8217182 Process for producing cyclic N-hydroxy imide compounds
07/10/2012US8217181 Dihalogen indolocarbazole monomers and poly (indolocarbazoles)
07/10/2012US8217177 Fused heterocyclic derivatives and methods of use
07/10/2012US8217169 Coupling agents for peptide synthesis
07/10/2012US8217167 Phenanthrylphenol linked pyrrolo [2, l-c] [l, 4] benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof
07/10/2012US8217166 Polyethylene glycolated superoxide dismutase mimetics
07/10/2012US8217067 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine
07/10/2012US8217049 Use of type V phosphodiesterase inhibitors in the treatment of exercise induced pulmonary hemorrhage in the equine
07/10/2012US8217026 Substituted porphyrins
07/10/2012CA2543820C Methods for synthesizing quinolinone compounds
07/10/2012CA2542647C Derivatives of n-heterocyclylmethylbenzamides, prepartion method thereof and application of same in therapeutics
07/10/2012CA2539426C Fused heterocyclic compounds
07/10/2012CA2513463C Gyrase inhibitors and uses thereof
07/10/2012CA2505195C Quinazolinones as potassium channel modulators
07/10/2012CA2494832C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
07/10/2012CA2360003C Tricyclic inhibitors of poly(adp-ribose) polymerases
1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 573